News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
Clinical - Drug Product News
Mapp Biopharmaceutical's Ebola Drug Production Set for Texas, Possibly North Carolina 9/30/2014
Par Pharmaceutical Companies, Inc. (PRX) Begins Shipment of Generic Exforge® 9/30/2014
Inergetics, Inc. Introduces Surgex® Warrior Sports Nutrition At Winn-Dixie 9/30/2014
LEO Pharma Announced New Taclonex® (Calcipotriene And Betamethasone Dipropionate) Topical Suspension, 0.005%/0.064% Indication For Treatment Of Scalp Plaque Psoriasis In Pediatric Patients Ages 12-17 9/30/2014
Pfizer (PFE) Starts New Viagra Commercials Targeting Women 9/30/2014
Janssen-Cilag International NV (JNJ) Release: CHMP Announces Positive Opinion For REZOLSTA™, A New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir And Cobicistat 9/29/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season 9/29/2014
Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, At World Dairy Expo 9/29/2014
Actavis (ACT) Will Keep Selling Alzheimer's Drug In U.S. For 60 Days 9/26/2014
Dr. Reddy's Laboratories Ltd. (RDY)’s Announces The Launch Of Levalbuterol Inhalation Solution, USP 9/24/2014
Sagent Pharmaceuticals, Inc. Announces The Introduction Of Oxaliplatin Injection, USP 9/24/2014
Regeneron Pharmaceuticals, Inc. (REGN) R&D Chief Reveals Allergy Drug May Be Darling Of Its Pipeline 9/23/2014
Anacor Pharmaceuticals, Inc. (ANAC) Announces Commercial Launch Of KERYDIN (tavaborole) Topical Solution, 5% In The United States 9/23/2014
Lannett Company, Inc. (LCI) Launches Oxycodone Hydrochloride Oral Solution 9/22/2014
CorMedix (CRMD) Release: Neutrolin Label Expansion Approved For The European Union 9/22/2014
60 Percent Of New York’s Hep C Patients Will Get Gilead Sciences, Inc. (GILD)'s Sovaldi 9/19/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ketorolac Tromethamine Injection, USP 9/18/2014
Roche (RHHBY) Introduces A New Fertility Test For Assessment Of Ovarian Reserve For Pregnancy 9/18/2014
Janssen Pharmaceutical Inc. Release: Prezcobix™ Now Available For Canadians Living With HIV 9/17/2014
New Product From Vireo Systems: pH-D Feminine Health Support 9/17/2014
Novartis AG (NVS), Roche (RHHBY) Cry Foul On New Swiss Pricing System 9/16/2014
Bayer HealthCare (BAY) Announces The Launch Of Aleve® PM: The First And Only OTC PM Pain Reliever With A Sleep Aid Plus The 12-Hour Pain Relieving Strength Of Aleve 9/15/2014
Easton Pharmaceuticals (OP: EAPH) Announces Preparations For North American Product(s) Launch 9/15/2014
Roche (RHHBY) Battles Counterfeit Rituxin Vials In Germany 9/15/2014
The Medicines Company (MDCO) To Review ORBACTIV™ (Oritavancin) Launch Readiness On Tuesday, September 16, 2014 9/12/2014
The Obesity Society Release: New FDA-Approved Weight Loss Drug Adds New Tool For Obesity Treatment 9/11/2014
EMD Serono Canada Inc. Announces Launch Of The Eeva® Test In Canada 9/11/2014
Regeneus (RGS.AX) Kvax Cancer Vaccine Available In Australia, U.S. Trial Begins 9/11/2014
Cerilliant Corporation Snap-N-Spike® | Snap-N-Shoot® Certified Reference Materials Now Available Through Sigma-Aldrich Corporation (SIAL) 9/10/2014
Marathon Pharmaceuticals, LLC Launches Zingo® (Lidocaine Hydrochloride Monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic To Manage Venous Access Pain 9/9/2014
Theravance, Inc. (THRX) Provides VIBATIV® (telavancin) Product Update 9/9/2014
National Institute for Clinical Excellence (NICE) Rejects Celgene (CELG)'s Abraxane For Pancreatic Cancer Over Limited Benefits, Cost 9/9/2014
Sagent Pharmaceuticals, Inc. Announces The Launch Of Ibandronate Sodium Injection 9/8/2014
Endo International plc (ENDP) Announces Launch Of Authorized Generic Of FORTESTA® Gel 9/8/2014
AstraZeneca PLC (AZN) Release: BYDUREON® Pen, A Treatment Option For Adults With Type 2 Diabetes, Now Available In Pharmacies 9/8/2014
Silvergate Pharmaceuticals Release: FDA Approves 2 New Indications For Epaned®, The First And Only Enalapril Powder For Oral Solution 9/8/2014
UK Watchdog Backs Alexion Pharmaceuticals Inc. (ALXN)'s "Very Expensive" Drug Soliris 9/5/2014
Genzyme Corporation (GENZ)'s New Rare Disease Pill Will Cost Patients $310,250 A Year 9/5/2014
Mylan Inc. (MYL) Launches Generic Boniva® Injection 9/5/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Launch Of Generic Baraclude® Tablets, 0.5mg And 1mg, In The United States 9/4/2014
National Institute for Clinical Excellence (NICE) Recommends Commissioning Of Eculizumab (Soliris®) For All Patients With aHUS In England 9/4/2014
Teva Pharmaceutical Industries Limited (TEVA) Launches SYNCare™ Home Administration Support Program For Patients On SYNRIBO® (Omacetaxine Mepesuccinate) For Injection 9/3/2014
Procter & Gamble (PG) Release: Vicks® Breaks Into Allergy And Sinus Category With The Introduction Of Qlearquil™ 9/3/2014
Iroko Pharmaceuticals Announces Inclusion Of ZORVOLEX® In Key 2015 National Formularies 9/3/2014
Cipla Ltd. Takes A Bite Out Of GlaxoSmithKline (GSK)'s Profits As Copy Of Top Asthma Drug Lauches In Germany, Sweden 9/2/2014
Lundbeck Inc. (LUN.CO) Announces Availability Of NORTHERA™ (droxidopa) Capsules In The U.S. For Symptomatic Neurogenic Orthostatic Hypotension 9/2/2014
BioTie Therapies Corp.: Selincro Enters The Market In Germany 8/29/2014
Janssen Research & Development Expands EXPLORER Global Cardiovascular Research Program To Evaluate The Role Of XARELTO® In Addressing Critical Medical Needs 8/29/2014
BBI Solutions Launches A Fully Validated Human Recombinant Cystatin C Antigen 8/27/2014
TNI BioTech Announces First Shipment Of Lodonal® To The Republic Of Panama And The Republic Of Malawi 8/27/2014
Ipsen (IPN.PA) Announces Second Resupply Of Increlex® (Mecasermin [Rdna Origin] Injection) In The U.S. In 2014 8/26/2014
Eli Lilly and Company (LLY) Release: New Type 2 Diabetes Treatment Jardiance® (empagliflozin) Tablets For Adults Now Available In U.S. Pharmacies 8/26/2014
Fera Pharmaceuticals Announces Launch of Moxatag® Authorized Generic 8/25/2014
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014
Pfizer Inc. (PFE) Release: Palbociclib Expanded Access Program Now Open To Eligible U.S. Patients With Hr+, Her2- Advanced Breast Cancer 8/21/2014
Telomere Biosciences LLC Announces: TELO-20 For Dogs, The World's First Telomere-Lengthening Supplement For Dogs, To Promote Healthy Aging And Longevity 8/21/2014
Lannett Company, Inc. (LCI) Comments On Utilization Of Digoxin 8/20/2014
Protein Sciences Corporation Release: Flublok® Influenza Vaccine Will Be Available At Over 230 Passport Health Locations Nationwide 8/19/2014
Mylan Inc. (MYL) Launches Generic Precedex™ Injection - Another Key Product Approval 8/19/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Germany By Hexal 8/18/2014
Fresenius Kabi AG Introduces Acetylcysteine Solution 10% In 4 Ml, 10 Ml And 30 Ml Vials 8/18/2014
National Institute for Clinical Excellence (NICE) And Johnson & Johnson (JNJ) Urged To End Zytiga Fiasco 8/15/2014
Pragma Pharmaceuticals Announces Re-Launch of Moxatag® 8/15/2014
U.S. Panel Says Seniors Should Get Pfizer Inc. (PFE)'s Prevnar 13 8/14/2014
PuraMed BioScience Completes the First Production of MigraPure® Gel 8/14/2014
Merck & Co., Inc. (MRK) Statement Regarding Role Of PNEUMOVAX® 23 (Pneumococcal Vaccine Polyvalent) In Updated ACIP Recommendations For Pneumococcal Vaccination In Adults 8/14/2014
Amneal Pharmaceuticals Announces Four New Generics 8/13/2014
Sanofi US (SNY) Launches Authorized Generic Version Of Eloxatin® (oxaliplatin Injection) 8/12/2014
Sanofi (France) (SAN.PA), PATH Roll Out First Large-Scale Batches Of Antimalarial Drug 8/12/2014
Another Controversial High Price Med: National Institute for Clinical Excellence (NICE) Rejects Roche (RHHBY)'s New $152,850 Breast Cancer Drug 8/11/2014
Mylan Inc. (MYL) Launches Generic Xeloda® Tablets 8/11/2014
Fresenius Kabi AG Release: Diprivan® (Propofol) Injectable Emulsion, USP Now Available In 10 Ml Vials 8/11/2014
BTG plc (BTG.L) Release: First Varicose Vein Patient Treated With FDA-Approved Varithena® (polidocanol Injectable Foam) 1% 8/11/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala 8/8/2014
NextSource Biotechnology Gains FDA Approval For Use Of Tradename Gleostine™ (Lomustine), An Anti-Cancer Chemotherapy Agent 8/8/2014
Suneva Medical's Regenica® Skin Care System Gets New Look 8/8/2014
A Little Drug From Questcor Pharmaceuticals, Inc. (QCOR) Generates Controversy And A $220 Million Medicare Bill 8/7/2014
Merck & Co., Inc. (MRK) Concerned For Diabetes Patients In Canada As Top Drugs Are Cut From Program 8/6/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Irinotecan Hydrochloride Injection, USP 8/5/2014
Cubist Pharmaceuticals, Inc. (CBST)’s Once-Daily SIVEXTRO™ (Tedizolid Phosphate) Available For Physician And Hospital Order In I.V. And Oral Formulations 8/5/2014
bioCSL Inc. Launches AFLURIA® Shipping Campaign For 2014-2015 Seasonal Influenza 8/5/2014
Gilead Sciences, Inc. (GILD) Battles To Shift Debate Over $1,000 Hepatitis Pills From Costs To Cures 8/5/2014
Troubled GlaxoSmithKline (GSK) Gets A Lift As Express Scripts Inc. Reinstates Lung Drug Advair 8/5/2014
Blow To Amgen (AMGN)'s Profits As Express Scripts Inc. Drops Drugs From List Of Preferred Drugs 8/4/2014
Tekmira Pharmaceuticals Corporation (TKMR) Says Ebola Drug Not Used To Treat U.S. Aid Workers 8/4/2014
Eli Lilly and Company (LLY) Release: Type 2 Diabetes: Jentadueto® (linagliptin and metformin hydrochloride) Tablets Label Updated To Include New Data On Blood Glucose Reductions In Treatment-Naive Adults With High Baseline A1C 8/4/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In Sweden By Sandoz, Inc. 8/4/2014
Certara Corporation Launches D360 In Japan To Improve Drug Discovery And Development Productivity 8/4/2014
Chiesi Farmaceutici SpA And uniQure Provide Update On Glybera® Launch 8/4/2014
PuraMed BioScience Rebrands Its Natural Migraine Relief Medication, Lipigesic M 7/31/2014
BioPharm Executive: Have Drugs Finally Been Priced Too High? 7/31/2014
GlaxoSmithKline (GSK)'s Tanzeum™ Is Now Available In Pharmacies In The U.S. 7/30/2014
INNOPHARMA Announces Launch Of Olanzapine For Injection, 10mg/Vial In Canada 7/30/2014
AstraZeneca PLC (AZN) Fights With Pediatrician Group Over Preemie Drug Guidelines 7/29/2014
Akrimax Pharmaceuticals Initiates CONTROL Patient Registry For Tirosint® (Levothyroxine Sodium) Capsules 7/29/2014
Perrigo Company (PRGO) Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 7/28/2014
The Upsher-Smith Laboratories Galaxy™ Portfolio Of Antiepileptic Drugs Now Available 7/28/2014
Boehringer Ingelheim Corporation Release: Benefits And Safety Of Pradaxa® (Dabigatran Etexilate Mesylate) Repeatedly Confirmed 7/24/2014
Abbott Introduces New Similac® Breastfeeding Supplement With DHA, Lutein And Vitamin E 7/24/2014
FDA Approves Flonase® Allergy Relief For Sale Over-The-Counter In The United States 7/24/2014
Daiichi Sankyo, Inc. (4568.t) And Eli Lilly and Company (LLY): Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel 7/23/2014
Third Product In Vernalis PLC (VNLPY.PK)’ Cough Cold Pipeline (CCP-08) Achieves Proof-Of-Concept 7/22/2014
Iroko Pharmaceuticals Continues To Expand Commercialization Of ZORVOLEX Ex-US 7/22/2014
BioTie Therapies Corp.: Selincro Enters The Market In Spain 7/22/2014
Sanofi Pasteur (SASY.PA) Begins Shipping Seasonal Influenza Vaccine For Upcoming 2014-2015 Season In United States 7/22/2014
Shire Release: Firazyr®: First Subcutaneous Treatment For Acute Attacks Of Rare And Serious Swelling Disorder Now Available In Canada 7/21/2014
BioAlliance Pharma Announces The Launch Of Sitavig® In The United States By Its Partner Innocutis 7/21/2014
Basilea Pharmaceutica (BSLN.SW) To Launch Zevtera®/Mabelio®) (ceftobiprole medocaril) In Europe Through A Commercial Services Provider 7/21/2014
Durata Therapeutics, Inc.  (DRTX) Announces The U.S. Launch Of Dalvance™ 7/18/2014
MediGene AG (MDGEF.PK)'s Drug Veregen® Launched In Canada 7/17/2014
NovaBay Pharmaceuticals, Inc. (NBY) Announces Direct US Marketing-Sales Campaign For New i-Lid™ Cleanser Product 7/16/2014
Celsion Corporation (CLN) Announces Commercialization Of Reagent Products 7/15/2014
Bial And moksha8 Announce Exclusive License For The Commercialization Of Eslicarbazepine Acetate (Zebinix® / Exalief®) In Brazil And Mexico 7/15/2014
EU Nations Join Forces Against Gilead Sciences, Inc. (GILD)'s "Exorbitant" Hepatitis C Drug 7/14/2014
Upsher-Smith Laboratories Announces Immediate Availability Of A Generic Equivalent To Qudexy™ XR (Topiramate) Extended-Release Capsules 7/14/2014
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE) 7/10/2014
NicOx SA (COX.PA) Focuses U S. Operations On National Launches Of Sjo™ And Retnagene™ And Restructures RPS® Licensing Agreement 7/10/2014
The International Myeloma Foundation Says IMNOVID® (Pomalidomide), The Newest Medication For Advanced Cases Of Multiple Myeloma, Is Approved For Reimbursement In Sweden, Spain, And Switzerland 7/10/2014
Kaleo Release: EVZIO™ (naloxone HCl injection) Auto-Injector Now Available In The United States For The Emergency Treatment Of Opioid Overdose 7/10/2014
Par Pharmaceutical, Inc. Begins Shipment Of Fluphenazine Decanoate Injection, USP 7/9/2014
Insight Pharmaceuticals Release: MONISTAT® Announces New Suite Of Complete Care™ Products 7/9/2014
PTC Therapeutics, Inc. (PTCT) Announces Expanded Access Program For Translarna™ (ataluren) 7/9/2014
Mylan Inc. (MYL) Launches Generic Micardis® Tablets 7/8/2014
Perrigo Company (PRGO) Announces FDA Final Approval For The Store Brand Equivalent To Advil® Congestion Relief Tablets, 200 mg/10 mg 7/8/2014
Skystar Bio-Pharmaceutical (CGPN) Launches Bovine Immunoglobulin G (IgG) Kits In China 7/8/2014
Novartis AG (NVS) Unveils Stronger Drug In Bid To Boost Malaria Treatment 7/7/2014
Tianyin Pharmaceutical Co, Inc. Receives GMP For Tablets Formulation In Early July 7/7/2014
Novartis AG (NVS) Begins Shipment Of Seasonal Influenza Vaccines To US Market For The 2014-2015 Season 7/3/2014
Upsher-Smith Laboratories Announces Launch Of The First And Only Generic Transdermal Testosterone Gel Available In Three Convenient Configurations 7/2/2014
Upsher-Smith Laboratories Launches Qudexy™ XR (Topiramate) Extended-Release Capsules For Treatment Of Specific Seizure Types 6/30/2014
Aqua Pharmaceuticals Announces Launch Of Cordran® Ointment (Flurandrenolide Ointment, USP) 0.05% 6/30/2014
NPS Pharmaceuticals, Inc. (NPSP) Release: FDA Approves Updated Labeling For Gattex® (Teduglutide [RDNA Origin]) For Injection To Include Long-Term Data 6/30/2014
Ohm Laboratories, Inc. To Launch Valsartan Tablets 6/27/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Duloxetine Delayed-Release Capsules USP 6/27/2014
Quest Products, Inc. Introduces New ProVent® Eczema And Psoriasis Spray® 6/25/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Paricalcitol Capsules 6/25/2014
Hetero Launches Darbepoetin Alfa, A Much Needed Biosimilar Anemia Treatment In India 6/19/2014
[1} Announces The Launch Of GLYDO™ (Lidocaine HCI Jelly USP, 2%) 6/19/2014
Manzo Pharmaceuticals Announces The Release Of Its Newest Product Tummy Relief A Natural Colic Remedy For Babies 6/18/2014
Sucampo Pharmaceuticals, Inc. (SCMP) Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation 6/18/2014
DermWorx Incorporated / LETI Laboratories S.L. To Launch Leading Atopic Skincare Line To The U.S. Market 6/17/2014
UK's Cost Agency Not Ready To Back Gilead Sciences, Inc. (GILD)'s Controversial Hepatitis C Drug 6/17/2014
Cepheid (CPHD) Announces European Release Of Xpert Carba-R, A Molecular Test For Rapid And Accurate Detection Of Carbapenemase-Producing Gram-Negative Bacteria 6/16/2014
Apricus Biosciences (APRI) Announces The Launch Of Its Topical Treatment For Erectile Dysfunction Vitaros® In The United Kingdom 6/16/2014
Takeda Pharmaceutical Co. Ltd. (TKPYY) Release: ENTYVIO™ (vedolizumab) Now Available In The United States For The Treatment Of Adults With Moderately To Severely Active Ulcerative Colitis And Crohn's Disease 6/16/2014
Italy To Fund Unapproved Use Of Roche (RHHBY) Drug To Cut Costs; Move Startles The Industry 6/13/2014
MediGene AG (MDGEF.PK) Announces Market Launch Of Veregen®: In Belgium, Denmark And Finland 6/12/2014
Forest Laboratories, Inc. (FRX) Announces Intention To Continue Marketing Both NAMENDA® TABLETS And Once-Daily NAMENDA XR® Into The Fall Of 2014 6/11/2014
Auxilium Pharmaceuticals (AUXL) Announces Launch Of Authorized Generic Version Of Testim (Testosterone Gel) 6/11/2014
Mylan Inc. (MYL) Launches Generic Actonel® Tablets, 150 mg 6/11/2014
Medivir AB (MVRBF) Release: OLYSIO™ Available Soon In All Nordic Countries For The Treatment Of Adults With Hepatitis C Genotype 1 And 4 Infection 6/10/2014
Mylan Inc. (MYL) Launches Generic Paraplatin® Injection 6/9/2014
Both Are Roche (RHHBY)'s Drugs, But Which One Could Save The U.S. $3 Billion? 6/5/2014
Norgen Biotek Corporation Launches 6 Novel Kits For The Isolation Of High-Quality Circulating Nucleic Acids From Blood, Plasma, Serum And Urine 6/4/2014
CorePharma LLC Announces The Launch Of Dextroamphetamine Sulfate Tablets, USP 6/4/2014
Paragon BioTeck Announces FDA Approved Phenylephrine Hydrochloride Ophthalmic Solution Readily Available 6/4/2014
Gilead Sciences Canada, Inc. (GILD) Release: Quebec Becomes First Province To Reimburse Sovaldi® For The Treatment Of Chronic Hepatitis C 6/3/2014
H2-Pharma Launches Authorized Generic LIPOFEN 6/3/2014
Mission Pharmacal Company Begins Exclusive Promotion Of Elestrin® (Estradiol Gel) 0.06% In The U.S. Market 5/30/2014
Mylan Inc. (MYL) Launches Generic Malarone® Tablets 5/29/2014
Genzyme Corporation (GENZ)'s Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE) 5/28/2014
Polyplus Transfection Launches A New Transfection Reagent For Bioproduction 5/28/2014
ULURU Inc. Announces Shipments Of Altrazeal® To Italy, Spain And Portugal 5/27/2014
Solara Labs Announces The Launch Of BariMelts® 5/27/2014
Pfizer Inc. (PFE) Brings Frequent Heartburn Relief Over-The-Counter With New Nexium® 24HR 5/27/2014
DiscoveRx Corporation Enables Predictive In Vitro Drug Combination Studies With Launch Of Biomap® Combo ELECT 5/21/2014
TOLMAR Pharmaceuticals Established To Market ELIGARD For Advanced Prostate Cancer In The U.S. And Puerto Rico 5/16/2014
ALK-Abello A/S's Partner For North America, Merck & Co., Inc. (MRK), Announces Launch Of RAGWITEK™ In Canada 5/15/2014
Mylan Inc. (MYL) Launches Generic Zyprexa Zydis® Tablets 5/14/2014
Negative National Institute for Clinical Excellence (NICE) Draft Guidance On Janssen Biotech Inc. (JNJ)'s Zytiga For Prostate Cancer 5/14/2014
Ipsen (IPN.PA) Announces A Step Forward In The Resupply Of Increlex® (Mecasermin [rDNA Origin] Injection) In The U.S. 5/13/2014
Veracyte, Inc. (VCYT) Launches Afirma® Malignancy Classifiers To Further Help Thyroid Nodule Patients Avoid Unnecessary Surgeries And Lower Healthcare Costs 5/13/2014
INSYS Therapeutics Issues Clarifying Statement 5/13/2014
Ajanta Pharma Announces The Launch Of Risperidone Tablets 5/9/2014
Actavis (ACT) Launches Generic Version Of Catapres-TTS® 5/8/2014
CorePharma LLC Launches Methylphenidate Hydrochloride Tablets USP 5/8/2014
Cumberland Pharmaceuticals (CPIX) Launches Vaprisol® Promotion 5/7/2014
Greer Labs Launches ORALAIR®, The First And Only Sublingual Allergy Immunotherapy Tablet With A Mix Of Five Grass Allergens For The Treatment Of Grass Pollen Allergy 5/5/2014
Otsuka Pharmaceutical Co., Ltd. Release: New Once-Monthly Treatment For Schizophrenia, ABILIFY MAINTENA™ (Aripiprazole For Prolonged Release Injectable Suspension), Now Available In Canada 5/5/2014
Covance Inc. (CVD) Launches New Brand: Solutions Made Real™ 5/2/2014
Access Pharmaceuticals (ACCP) MuGard Selected For Cover Article In The Print Edition Of The Journal Cancer 5/1/2014
Alexza Pharmaceuticals, Inc. (ALXA) Announces The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In The Nordic Countries 5/1/2014
MyoScience Inc. Release: Novel Pain Treatment Is Now Available: Iovera System Harnesses The Power Of Cold To Block Pain 5/1/2014
Gilead Sciences, Inc. (GILD)'s Solvadi Strikes Again: $1,000 A Pill Rattles Medicaid Programs 4/30/2014
Medivir AB (MVRBF) Release: Adasuve Will Now Be Launched In Sweden, Norway, Finland, And Denmark 4/30/2014
GlaxoSmithKline (GSK)/Theravance, Inc. (THRX) Release: Anoro™ Ellipta® Now Available In The U.S. For Treatment Of COPD 4/28/2014
Dr. Reddy's Laboratories Ltd. (RDY) Announces The Launch Of Fenofibrate Capsules, USP 43 Mg And 130 Mg 4/23/2014
Zogenix, Inc. (ZGNX) Responds To Governor's Action Singling Out Zohydro™ ER In Massachusetts, Encourages Officials To Consider Patient Needs And Effective Class-Wide Measures 4/23/2014
Catalyst Pharmaceutical Partners, Inc. (CPRX) Announces Initiation Of An Expanded Access Program To Provide Firdapse At No Cost To U.S. Patients With Lambert-Eaton Myasthenic Syndrome 4/23/2014
NovaBay Pharmaceuticals, Inc. (NBY) Introduces Advanced I-Lid Cleanser For Cleaning Eyelids And Skin Around The Eye 4/23/2014
PuriCore Launches NovaZo Wound Hydrogel For Equine And Companion Animals 4/23/2014
Heat On Roche (RHHBY) To Cut Kadcyla Price After National Institute for Clinical Excellence (NICE) Says "No" 4/23/2014
Oculus Innovative Sciences, Inc. (OCLS)' Partner, More Pharma Corporation, Launches Microcyn®-Based Oral And Throat Infection Treatment Product In Mexico 4/22/2014
Sagent Pharmaceuticals, Inc. Announces The Reintroduction Of Adenosine Injection, USP 4/21/2014
Stolen Roche (RHHBY) Cancer Drug Found On Market 4/18/2014
Mylan Inc. (MYL) Launches First Generic ORTHO EVRA® Patch 4/17/2014
Anika Therapeutics (ANIK) Announces First U.S. Commercial Sale Of Monovisc® 4/16/2014
Apricus Biosciences (APRI)' Partner In The United Kingdom Accepts First Shipment Of Vitaros® 4/16/2014
IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic RENVELA® 4/16/2014
Dr. Reddy's Laboratories Ltd. (RDY)’ Announces The Launch Of Eszopiclone Tablets C-IV 4/16/2014



//-->